| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |